ABRYTOP Trademark

Trademark Overview


On Wednesday, April 6, 2022, a trademark application was filed for ABRYTOP with the United States Patent and Trademark Office. The USPTO has given the ABRYTOP trademark a serial number of 97348833. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, August 19, 2024. This trademark is owned by TEVA PHARMACEUTICALS USA, Inc.. The ABRYTOP trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations but not including vaccines or pharmaceuticals for the tr...
abrytop

General Information


Serial Number97348833
Word MarkABRYTOP
Filing DateWednesday, April 6, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, August 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations but not including vaccines or pharmaceuticals for the treatment of respiratory viruses, diseases, and disorders
Pseudo MarkABRY TOP

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events


Event DateEvent Description
Saturday, April 9, 2022NEW APPLICATION ENTERED
Monday, April 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 20, 2022ASSIGNED TO EXAMINER
Monday, September 26, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, November 21, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Thursday, December 15, 2022POST PUBLICATION AMENDMENT RECEIVED
Thursday, December 15, 2022TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, January 10, 2023ASSIGNED TO PETITION STAFF
Wednesday, January 11, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, January 13, 2023CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, February 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 27, 2024SOU EXTENSION 2 FILED
Wednesday, August 16, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 16, 2023SOU EXTENSION 1 FILED
Wednesday, August 16, 2023SOU EXTENSION 1 GRANTED
Friday, August 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 27, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, February 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 27, 2024SOU EXTENSION 2 GRANTED
Monday, August 19, 2024SOU TEAS EXTENSION RECEIVED
Monday, August 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 19, 2024SOU EXTENSION 3 FILED
Monday, August 19, 2024SOU EXTENSION 3 GRANTED